Trial intelligence / Profile preview

Eplerenone versus doxazosin effects on insulin action in mild essential hypertension

2007-004689-42Phase 4Completed

Sponsor
Belfast Health and Social Care Trust
Start
Jun 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4 trial of eplerenone and doxazosin in essential hypertension (2 arms), sponsored by Belfast Health and Social Care Trust. Primary endpoint: Insulin action. Started Jun 2008; status: completed.

02

Drugs

eplerenonedoxazosin
03

Conditions

essential hypertension

Beyond the preview

Go deeper on 2007-004689-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004689-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call